Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2019

Open Access 01.12.2019 | Research

Significance of bile culture surveillance for postoperative management of pancreatoduodenectomy

verfasst von: Keishi Sugimachi, Tomohiro Iguchi, Yohei Mano, Masaru Morita, Masaki Mori, Yasushi Toh

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2019

Abstract

Background

The management of infectious complications is important in pancreatoduodenectomy (PD). We sought to determine the significance of preoperative surveillance bile culture in perioperative management of PD.

Methods

This study enrolled 69 patients who underwent PD for malignant tumors at a single institute between 2014 and 2017. Surveillance bile culture was performed before or during surgery. Correlations between the incidence of infectious postoperative complications and clinicopathological parameters, including bile cultures, were evaluated.

Results

Preoperative positive bile culture was confirmed in 28 of 51 patients (55%). Bile culture was positive in 27 of 30 cases (90%) with preoperative biliary drainage, and 1 of 21 cases (5%) without drainage (p < 0.01). Preoperative isolated microorganisms in bile were consistent with those detected in surgical sites in 11 of 27 cases (41%). Cases with positive multi-drug-resistant bacteria in preoperative bile culture showed significantly higher incisional SSI after PD (p = 0.01). The risk factors for the incidence of organ/space SSI were soft pancreatic texture (p = 0.01) and smoking history (p = 0.02) by multivariate analysis. Preoperative positive bile culture was neither associated with organ/space SSI nor overall postoperative complications.

Conclusions

Preoperative surveillance bile culture is useful for the management of wound infection, prediction of causative pathogens for infectious complications, and the selection of perioperative antibiotic prophylaxis.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
MDR
Multi-drug resistant
PD
Pancreatoduodenectomy
POPF
Postoperative pancreatic fistula
SSI
Surgical site infection

Background

Pancreatoduodenectomy (PD) is the only curative option for pancreatic, biliary, and duodenal malignant tumors. Perioperative management of patients undergoing PD has been dramatically improved in past few decades, but the morbidity still ranges from 20 to 50% [1, 2]. The complication and death rates of PD mainly depend on major infectious complications, including postoperative pancreatic fistula (POPF) and biliary leakage, and many other host factors, such as infection, the severity of jaundice, nutritional status, and impaired organ functions [3, 4].
Obstructive jaundice is the most common symptom for periampullary and ampullary tumors that need PD; thus, biliary drainage has been commonly performed. Preoperative biliary drainage re-establishes entero-hepatic circulation, provides symptomatic relief to patients with pruritus and cholangitis, and serves as a temporizing measure if surgery is delayed or neoadjuvant therapy is considered [5]. However, controversy remains about the pre-operative management of obstructive jaundice undergoing planned PD, because bacterobilia induced by biliary drainage has been reported to be associated with postoperative infectious complication and also even triggers the development of POPF [69]. Several studies reported the importance of specific prophylaxes based on bile culture to prevent postoperative complications, but preoperative antibiotics could potentially induce colonization of multi-drug-resistant (MDR) pathogens in the biliary tract [10, 11]. Though both claims related to biliary drainage may be logically correct, it is important to care and strictly manage biliary infection before PD.
To establish effective and safe strategies for prophylaxis of perioperative infectious complication, more accurate information on the incidence of perioperative biliary infection in patients who have undergone PD is needed. Therefore, we conducted a retrospective study of surveillance bile culture to analyze recent trends and significance of biliary infection on the perioperative outcome of PD.

Methods

Patients

A retrospective cohort study was performed with 69 consecutive patients who underwent PD at a single institute (Kyushu Cancer Center) between the years 2014 and 2017. Data from all these patients were collected from medical charts and analyzed. The demographic data of patients are summarized in Table 1.
Table 1
Demographics and clinical characteristics of the study population
Factor
Number
Sex
Male/female
45/24
Age
years
67.3 ± 9.9
Disease
Pancreas tumor/bile duct tumor/duodenal tumor
40/22/7
Smoking history
Current (never or ever)
17 (24.6%)
Body mass index
 
22.3 ± 2.9
Diabetes mellitus
 
22 (31.9%)
Preoperative biliary stent placement
 
34 (49.3%)
Surgical procedure
PD/PPPD/SSPPD
11/8/50
Episode of preoperative cholangitis
 
13 (18.9%)
Abbreviations: PD pancreatoduodenectomy, PPPD pylorus preserving pancreatoduodenectomy, SSPPD subtotal stomach preserving pancreatoduodenectomy

Perioperative management

Preoperative biliary drainage was performed in 34 of 69 patients (49%). Endoscopic retrograde (internal) biliary drainage was done in 30 cases (43%), endoscopic nasobiliary drainage was done in 2 cases (2%), and percutaneous transhepatic biliary drainage was done in 2 cases (2%). Patients treated with antimicrobial agents for high fever or abnormal liver function tests were diagnosed as cholangitis. As a surveillance bile culture, bile specimens were collected at the time of either preoperative biliary drainage procedure or surgery. Multi-drug-resistant pathogens were defined as described elsewhere [12, 13].
The child method was applied for the reconstruction of PD. An internal or external stent was placed at pancreatojejunostomy, and the abdominal cavity was routinely drained using closed suction tubes in all patients. Second-generation cephalosporins were used as prophylactic antibiotics for all patients at least 2 days after operation without regard to the preoperative bile culture.
All infectious complications were proven by a positive culture of purulent discharge. POPF was defined according to the International Study Group of Pancreatic Fistula [14], and the grade of complication was defined by Clavien-Dindo classification [15].

Statistical analysis

All statistical analyses were performed using JMP 13.0 software (SAS; Cary, NC, USA). All variables were expressed as the mean ± standard deviation. Continuous variables were compared using the Mann–Whitney U test. Categorical data were compared using the χ2 test. Logistic regression analysis was performed to identify the independent predictors of complications. A p value of < 0.05 was regarded as statistically significant.

Results

Pre- and intra-operative surveillance bile culture

Preoperative and intraoperative bile culture was performed in 12 (17%) and 46 patients (67%), respectively. Both pre- and intra-operative bile culture were done in 7 patients; thus, surveillance bile culture was done in 51 patients (74%) overall. Bile culture was positive in 28 of 51 patients (55%), and MDR pathogens were detected in 11 of 51 patients (22%). In 7 patients, those both pre- and intra-operative bile culture were done, the bile culture was positive at preoperative drainage in 4 cases and became positive after drainage (intraoperatively) in 3 cases. In 3 of 4 cases, the MDR pathogens matched between preoperative and intraoperative cultures. Detected MDR pathogens were Enterobacter species in 7, methicillin-resistant Staphylococcus aureus in 2, Pseudomonas species in 1, and extended spectrum β-lactamase-producing strains in 1 case. Bile culture was positive in 27 of 30 cases (90%) with preoperative biliary drainage, and 1 of 21 cases (5%) without drainage with statistically significant difference (p < 0.01). All 11 patients those MDR pathogens were detected had undergone biliary drainage. MDR pathogens were detected by preoperative culture in 2 patients, intraoperative culture in 8 patients, and both in 1 patient.

Postoperative complications

Relationship between surveillance bile culture and postoperative complications was analyzed in 51 cases those surveillance bile culture was done (Table 2). Incisional and organ/space surgical site infection (SSI) occurred in 6 (12%) and 33 (65%) cases, respectively. The occurrence of incisional SSI was significantly higher in the cases with MDR pathogen positive in bile culture (p = 0.01). There was no significant correlation between the morbidity of organ/space SSI and surveillance bile culture.
Table 2
Postoperative complications and surveillance bile culture
Complication
All cases
Bile culture positive
p value
MDR pathogens positive
p value
(n = 51)
(n = 28)
(n = 11)
Incisional SSI (%)
6 (12)
4 (14)
0.53
4 (36)
0.01
Organ/space SSI (%)
33 (65)
18 (64)
0.95
7 (63)
0.93
 Bile leakage (%)
4 (8)
2 (7)
0.84
1 (9)
0.86
 Pancreatic fistula (%)
21 (41)
12 (43)
0.79
4 (36)
0.71
 Cholangitis (%)
3 (6)
2 (7)
0.67
1 (9)
0.63
 Enteritis (%)
3 (6)
2 (7)
0.67
1 (9)
0.63
Clavien-Dindo ≥ 3 complication (%)
16 (31)
7 (25)
0.28
3 (27)
0.74
Abbreviations: SSI surgical site infection, MDR multi-drug resistance

Coincidence of pre-operative bile culture and post-operative abdominal fluid culture

Bile cultures were postoperatively obtained only in 7 cases because external biliary drainage was not applied in most cases. In the postoperative course, the culture of abdominal fluid from intra-abdominal drains was obtained from 54 of the 69 patients. The results of preoperative bile culture and postoperative abdominal fluid culture were compared. The postoperative culture was positive in 37 cases (68%), and MDR pathogens were positive in 23 cases (43%). Both pre- and post-operative cultures were obtained in 48 cases. The coincidence of pre- and post-operative culture was examined in 26 cases, and those preoperative bile cultures were positive. The coincidence of pathogens was observed in 11 cases (42%) (Table 3), and 10 out of these 11 cases, the detected bacteria were causative pathogens of SSI. In 10 cases of MDR pathogen testing positive in preoperative bile culture, 8 (80%) showed the same pathogens in abdominal fluid postoperatively, and the rate of coincidence of detected pathogens was significantly higher in cases with MDR-positive compared to non MDR-positive (p < 0.01, Table 3). Detected MDR pathogens were Enterobacter species in 5, methicillin-resistant Staphylococcus aureus in 2, and Pseudomonas species in 1 case.
Table 3
Coincidence of pathogens in preoperative and postoperative culture
Culture
Coincidence of pathogens
Non-coincidence of pathogens
p value
(n = 11)
(n = 15)
Drug sensitive pathogen positive (n = 16)
3 (19%)
13 (81%)
< 0.01
Multi-drug resistant pathogen positive (n = 10)
8 (80%)
2 (20%)
 

Risk factors associated with morbidity of organ/space SSI

Risk factors associated with morbidity of organ/space SSI were analyzed. In univariate analysis, diagnosis of pancreatic adenocarcinoma, operative time ≥ 360 min, blood loss ≥ 400 g, soft pancreatic texture, and main pancreatic duct diameter ≤ 3 mm were the risk factors of occurrence of organ/space SSI (Table 4). In multivariate analysis, smoking history and pancreatic texture were the independent risk factors associated with organ/space SSI (Table 4). The preoperative bile culture was not statistically associated with the occurrence of organ/space SSI.
Table 4
Risk factors associated with morbidity of organ/space surgical site infection
Factors
Univariate analysis
Multivariate analysis
oSSI(−) n = 26
oSSI(+) n = 43
p value
hazard ratio (95% CI)
p value
Diagnosis
PDAC/others
20/6
20/23
0.01
  
Smoking history
(+)/(−)
4/22
13/30
0.16
32.7 (1.65–647)
0.02
Operative time (min)
≥ 360/≤ 359
13/13
32/11
0.04
  
Blood loss (g)
≥ 400/≤ 399
16/10
14/29
0.02
  
Pancreatic texture
Soft/hard
5/21
31/11
< 0.01
17.2 (1.77–168)
0.01
Main pancreatic duct diameter (mm)
≤ 3/≥ 4
9/17
26/13
0.01
  
Preoperative bile culture
Positive/negative
10/16
18/25
0.78
  
Drug resistant pathogen in preoperative bile culture
Positive/negative
4/22
7/36
0.92
  
Abbreviations: PDAC pancreatic adenocarcinoma, oSSI organ/space surgical site infection, CI confident interval

Discussion

We have shown that bacterobilia is induced by preoperative biliary obstruction and drainage and associated with higher incidence of incisional SSI. The coincidence of pathogens, especially MDR, between bile and post-operative infectious lesions, such as intraabdominal fluid, were frequently observed in our series. These results indicated that colonization in bile due to pre-operative biliary drainage could be causative pathogens of postoperative infectious complications.
Postoperative pancreatic fistula is a major determinant of postoperative infectious complications, and it is associated with mortality of PD. Thus, the management of infectious complications is critical in perioperative care [16, 17]. Our multivariate analysis indicated that bacterobilia is not an independent risk factor for organ/space SSI, but pancreatic texture and smoking history were associated with the incidence of SSI. Those results were also observed by the analysis of 51 cases those surveillance bile culture was done (data not shown). Soft pancreatic parenchyma and small pancreatic duct diameter are a well-established risk factor of POPF [18, 19], and our present data also indicated that risk factors for POPF are dominant compared with bacterobilia in the incidence of organ/space SSI.
The present data, consistent with the literature, showed that preoperative biliary drainage caused bacterobilia [6]. Benefits of preoperative biliary drainage for patients undergoing PD remain largely controversial [7, 2022]. Several studies question its value given morbidity and complications associated with biliary infection. However, decreased jaundice can relieve patient symptom and improve immunonutritious conditions through entero-hepatic circulation [23]. More importantly, neoadjuvant preoperative chemotherapy is becoming more common for borderline resectable pancreatic adenocarcinoma; thus, preoperative biliary drainage is essential for at least certain patient groups [24]. Our study indicated that the most serious complications mainly depend on the risk factors of POPF, but not on bacterobilia; thus, biliary drainage is acceptable if necessary. In cases with biliary drainage, it is important to apply strict management to prevent infectious post-operative complications. We recommend the use of specific antibiotics based on surveillance bile culture to avoid colonization of MDR bacteria and to manage surgical incisions as contaminated wounds. Our study supports the theory reported by Okamura et al. that preoperative bile culture-target prophylactic antibiotics decreased SSI following hepato-pancreato-biliary surgery [25].
We acknowledge limitations of this non-randomized study, including relatively small sample size. Many studies reported that bile is contaminated in patients undergoing PD after biliary drainage [610, 20, 21]. Our study agrees with the importance of surveillance bile culture for management of patients with PD. The present study described the impact of bacterobilia caused by MDR pathogens, which is becoming more important with the current spread of antibiotic-resistant bacteria, not only in bile but in postoperative infectious lesions.

Conclusions

Higher incidence of incisional SSI is anticipated in patients undergoing PD with biliary drainage due to bacterobilia. Management of wounds as contaminated and use of appropriate prophylactic antimicrobial agents based on surveillance bile culture are needed to improve operative outcomes.

Acknowledgements

The authors thank Drs. Tomonori Nakanoko, Hideo Uehara, Masahiko Sugiyama, Mitsuhiko Ohta, and Masahiko Ikebe for their contribution to the clinical data collection. The also authors thank Ms. Ai Ohyama and Ms. Emiko Miyamoto for their technical assistance.
The study was approved by the ethics committee of the Kyushu Cancer Center (No. 2019-54).
The study was undertaken with the patient’s consent.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2011;18:2126–35.CrossRef Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2011;18:2126–35.CrossRef
2.
Zurück zum Zitat Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, Obertop H. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.CrossRef Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, Obertop H. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.CrossRef
3.
Zurück zum Zitat Shrikhande SV, Sivasanker M, Vollmer CM, Friess H, Besselink MG, Fingerhut A, Yeo CJ, Fernandez-delCastillo C, Dervenis C, Halloran C, et al. Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2017;161:1221–34.CrossRef Shrikhande SV, Sivasanker M, Vollmer CM, Friess H, Besselink MG, Fingerhut A, Yeo CJ, Fernandez-delCastillo C, Dervenis C, Halloran C, et al. Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2017;161:1221–34.CrossRef
4.
Zurück zum Zitat Sugimachi K, Iguchi T, Mano Y, Nishijima T, Nakanoko T, Uehara H, Sugiyama M, Ohta M, Ikebe M, Morita M, et al. The impact of immunonutritional and physical status on surgical outcome after pancreaticoduodenectomy in elderly Patients. Anticancer Res. 2019;39:6347–53.CrossRef Sugimachi K, Iguchi T, Mano Y, Nishijima T, Nakanoko T, Uehara H, Sugiyama M, Ohta M, Ikebe M, Morita M, et al. The impact of immunonutritional and physical status on surgical outcome after pancreaticoduodenectomy in elderly Patients. Anticancer Res. 2019;39:6347–53.CrossRef
5.
Zurück zum Zitat Sauvanet A, Boher JM, Paye F, Bachellier P, Sa Cuhna A, Le Treut YP, Adham M, Mabrut JY, Chiche L, Delpero JR, French Association of S. Severe jaundice increases early severe morbidity and decreases long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Am Coll Surg. 2015;221:380–9.CrossRef Sauvanet A, Boher JM, Paye F, Bachellier P, Sa Cuhna A, Le Treut YP, Adham M, Mabrut JY, Chiche L, Delpero JR, French Association of S. Severe jaundice increases early severe morbidity and decreases long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Am Coll Surg. 2015;221:380–9.CrossRef
6.
Zurück zum Zitat Lee PJ, Podugu A, Wu D, Lee AC, Stevens T, Windsor JA. Preoperative biliary drainage in resectable pancreatic cancer: a systematic review and network meta-analysis. HPB (Oxford). 2018;20:477–86.CrossRef Lee PJ, Podugu A, Wu D, Lee AC, Stevens T, Windsor JA. Preoperative biliary drainage in resectable pancreatic cancer: a systematic review and network meta-analysis. HPB (Oxford). 2018;20:477–86.CrossRef
7.
Zurück zum Zitat Mussle B, Hempel S, Kahlert C, Distler M, Weitz J, Welsch T. Prognostic impact of bacterobilia on morbidity and postoperative management after pancreatoduodenectomy: a systematic review and meta-analysis. World J Surg. 2018;42:2951–62.CrossRef Mussle B, Hempel S, Kahlert C, Distler M, Weitz J, Welsch T. Prognostic impact of bacterobilia on morbidity and postoperative management after pancreatoduodenectomy: a systematic review and meta-analysis. World J Surg. 2018;42:2951–62.CrossRef
8.
Zurück zum Zitat Ohgi K, Sugiura T, Yamamoto Y, Okamura Y, Ito T, Uesaka K. Bacterobilia may trigger the development and severity of pancreatic fistula after pancreatoduodenectomy. Surgery. 2016;160:725–30.CrossRef Ohgi K, Sugiura T, Yamamoto Y, Okamura Y, Ito T, Uesaka K. Bacterobilia may trigger the development and severity of pancreatic fistula after pancreatoduodenectomy. Surgery. 2016;160:725–30.CrossRef
9.
Zurück zum Zitat Cortes A, Sauvanet A, Bert F, Janny S, Sockeel P, Kianmanesh R, Ponsot P, Ruszniewski P, Belghiti J. Effect of bile contamination on immediate outcomes after pancreaticoduodenectomy for tumor. J Am Coll Surg. 2006;202:93–9.CrossRef Cortes A, Sauvanet A, Bert F, Janny S, Sockeel P, Kianmanesh R, Ponsot P, Ruszniewski P, Belghiti J. Effect of bile contamination on immediate outcomes after pancreaticoduodenectomy for tumor. J Am Coll Surg. 2006;202:93–9.CrossRef
10.
Zurück zum Zitat Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T. Specific antibiotic prophylaxis based on bile cultures is required to prevent postoperative infectious complications in pancreatoduodenectomy patients who have undergone preoperative biliary drainage. World J Surg. 2007;31:2230–5.CrossRef Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T. Specific antibiotic prophylaxis based on bile cultures is required to prevent postoperative infectious complications in pancreatoduodenectomy patients who have undergone preoperative biliary drainage. World J Surg. 2007;31:2230–5.CrossRef
11.
Zurück zum Zitat Sugawara G, Yokoyama Y, Ebata T, Igami T, Yamaguchi J, Mizuno T, Yagi T, Nagino M. Preoperative biliary colonization/infection caused by multidrug-resistant (MDR) pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection. Surgery. 2018;163:1106–13.CrossRef Sugawara G, Yokoyama Y, Ebata T, Igami T, Yamaguchi J, Mizuno T, Yagi T, Nagino M. Preoperative biliary colonization/infection caused by multidrug-resistant (MDR) pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection. Surgery. 2018;163:1106–13.CrossRef
12.
Zurück zum Zitat Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRef Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRef
13.
Zurück zum Zitat Sugawara G, Yokoyama Y, Ebata T, Mizuno T, Yagi T, Ando M, Nagino M. Duration of antimicrobial prophylaxis in patients undergoing major hepatectomy with extrahepatic bile duct resection: a randomized controlled trial. Ann Surg. 2018;267:142–8.CrossRef Sugawara G, Yokoyama Y, Ebata T, Mizuno T, Yagi T, Ando M, Nagino M. Duration of antimicrobial prophylaxis in patients undergoing major hepatectomy with extrahepatic bile duct resection: a randomized controlled trial. Ann Surg. 2018;267:142–8.CrossRef
14.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M. International Study Group on Pancreatic Fistula D: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.CrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M. International Study Group on Pancreatic Fistula D: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.CrossRef
15.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef
16.
Zurück zum Zitat Vollmer CM Jr, Sanchez N, Gondek S, McAuliffe J, Kent TS, Christein JD, Callery MP, Pancreatic Surgery Mortality Study G. A root-cause analysis of mortality following major pancreatectomy. J Gastrointest Surg. 2012;16:89–102 discussion 102-103.CrossRef Vollmer CM Jr, Sanchez N, Gondek S, McAuliffe J, Kent TS, Christein JD, Callery MP, Pancreatic Surgery Mortality Study G. A root-cause analysis of mortality following major pancreatectomy. J Gastrointest Surg. 2012;16:89–102 discussion 102-103.CrossRef
17.
Zurück zum Zitat De Pastena M, Paiella S, Marchegiani G, Malleo G, Ciprani D, Gasparini C, Secchettin E, Salvia R, Bassi C. Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: results from a high-volume center. Surgery. 2017;162:792–801.CrossRef De Pastena M, Paiella S, Marchegiani G, Malleo G, Ciprani D, Gasparini C, Secchettin E, Salvia R, Bassi C. Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: results from a high-volume center. Surgery. 2017;162:792–801.CrossRef
18.
Zurück zum Zitat Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216:1–14.CrossRef Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216:1–14.CrossRef
19.
Zurück zum Zitat Sugimoto M, Takahashi S, Kojima M, Kobayashi T, Gotohda N, Konishi M. In patients with a soft pancreas, a thick parenchyma, a small duct, and fatty infiltration are significant risks for pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg. 2017;21:846–54.CrossRef Sugimoto M, Takahashi S, Kojima M, Kobayashi T, Gotohda N, Konishi M. In patients with a soft pancreas, a thick parenchyma, a small duct, and fatty infiltration are significant risks for pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg. 2017;21:846–54.CrossRef
22.
Zurück zum Zitat Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Yoshikawa T, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:25–30.CrossRef Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Yoshikawa T, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:25–30.CrossRef
23.
Zurück zum Zitat Yokoyama Y, Ebata T, Igami T, Sugawara G, Nagino M. Is the enteral replacement of externally drained pancreatic juice valuable after pancreatoduodenectomy? Surg Today. 2014;44:252–9.CrossRef Yokoyama Y, Ebata T, Igami T, Sugawara G, Nagino M. Is the enteral replacement of externally drained pancreatic juice valuable after pancreatoduodenectomy? Surg Today. 2014;44:252–9.CrossRef
24.
Zurück zum Zitat Javed AA, Wright MJ, Siddique A, Blair AB, Ding D, Burkhart RA, Makary M, Cameron JL, Narang A, Herman J, et al. Outcome of patients with borderline resectable pancreatic cancer in the contemporary era of neoadjuvant chemotherapy. J Gastrointest Surg. 2018. Javed AA, Wright MJ, Siddique A, Blair AB, Ding D, Burkhart RA, Makary M, Cameron JL, Narang A, Herman J, et al. Outcome of patients with borderline resectable pancreatic cancer in the contemporary era of neoadjuvant chemotherapy. J Gastrointest Surg. 2018.
25.
Zurück zum Zitat Okamura K, Tanaka K, Miura T, Nakanishi Y, Noji T, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S. Randomized controlled trial of perioperative antimicrobial therapy based on the results of preoperative bile cultures in patients undergoing biliary reconstruction. J Hepatobiliary Pancreat Sci. 2017;24:382–93.CrossRef Okamura K, Tanaka K, Miura T, Nakanishi Y, Noji T, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S. Randomized controlled trial of perioperative antimicrobial therapy based on the results of preoperative bile cultures in patients undergoing biliary reconstruction. J Hepatobiliary Pancreat Sci. 2017;24:382–93.CrossRef
Metadaten
Titel
Significance of bile culture surveillance for postoperative management of pancreatoduodenectomy
verfasst von
Keishi Sugimachi
Tomohiro Iguchi
Yohei Mano
Masaru Morita
Masaki Mori
Yasushi Toh
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2019
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1773-7

Weitere Artikel der Ausgabe 1/2019

World Journal of Surgical Oncology 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.